Staged Kidney Transplantation During Combined Heart/Kidney Transplantation

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 7, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2035

Conditions
Heart FailureChronic Kidney DiseaseEnd-stage Kidney Disease
Interventions
OTHER

Planned delayed implantation of kidney allograft with ex vivo machine perfusion kidney preservation.

During combined heart and kidney transplantation, heart and kidney allografts may be implanted during a single operative event, or with delayed kidney implantation in a second operative event. Timing of the delay is often determined by recipient stability and kidney availability; however, clinicians must balance recipient factors with accumulating cold ischemic time of the kidney allograft. This study uses hypothermic oxygenated machine perfusion to reduce ischemic injury to the kidney allograft and allow for improved recipient stability with planned delayed implantation of the kidney graft. Delays will allow for at least 6 hours of hypothermic oxygenated machine perfusion prior to implantation.

Trial Locations (1)

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER